CLSD - Clearside BioMedical, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
6.44
+0.51 (+8.60%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close5.93
Open5.92
Bid4.95 x 700
Ask6.30 x 100
Day's Range5.92 - 6.57
52 Week Range5.30 - 10.36
Volume472,831
Avg. Volume166,645
Market Cap163.205M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-2.15
Earnings DateMar 12, 2018 - Mar 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.20
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    Clearside Biomedical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference

    ALPHARETTA, Ga., Dec. 20, 2017-- Clearside Biomedical, Inc., a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced today ...

  • Are Clearside BioMedical Inc’s (NASDAQ:CLSD) Interest Costs Too High?
    Simply Wall St.2 months ago

    Are Clearside BioMedical Inc’s (NASDAQ:CLSD) Interest Costs Too High?

    While small-cap stocks, such as Clearside BioMedical Inc (NASDAQ:CLSD) with its market cap of $169.54M, are popular for their explosive growth, investors should also be aware of their balance sheetRead More...

  • Capital Cube2 months ago

    ETFs with exposure to Clearside Biomedical, Inc. : December 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Clearside Biomedical, Inc. Here are 5 ETFs with the largest exposure to CLSD-US. Comparing the performance and risk of Clearside Biomedical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Clearside Biomedical, Inc. :CLSD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017
    Capital Cube3 months ago

    Clearside Biomedical, Inc. :CLSD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017

    Categories: Yahoo FinanceGet free summary analysis Clearside Biomedical, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Clearside Biomedical, Inc. – Invitae Corp. and Natera, Inc. (NVTA-US and NTRA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.16 million, Net ... Read more (Read more...)

  • ACCESSWIRE3 months ago

    Clearside Biomedical, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 8, 2017 / Clearside Biomedical, Inc. (NASDAQ: CLSD ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 8, 2017 at 8:30 AM Eastern ...

  • Capital Cube4 months ago

    ETFs with exposure to Clearside Biomedical, Inc. : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Clearside Biomedical, Inc. Here are 5 ETFs with the largest exposure to CLSD-US. Comparing the performance and risk of Clearside Biomedical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to Clearside Biomedical, Inc. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Clearside Biomedical, Inc. Here are 5 ETFs with the largest exposure to CLSD-US. Comparing the performance and risk of Clearside Biomedical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Clearside Biomedical, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Clearside Biomedical, Inc. Here are 5 ETFs with the largest exposure to CLSD-US. Comparing the performance and risk of Clearside Biomedical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Clearside Biomedical, Inc. :CLSD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
    Capital Cube6 months ago

    Clearside Biomedical, Inc. :CLSD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Clearside Biomedical, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Clearside Biomedical, Inc. – Invitae Corp. and Natera, Inc. (NVTA-US and NTRA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.13 million, Net ... Read more (Read more...)

  • ACCESSWIRE6 months ago

    Investor Network: Clearside Biomedical, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Clearside Biomedical, Inc. (NASDAQ: CLSD ) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at 8:30 ...